07.21.25 -- Efficient And Scalable Preparative HPLC Solutions

Review our full service offering and learn how we can help advance your project toward commercialization with speed and efficiency.

Discover the efficiency and scalability of these chromatography columns designed for fast and safe packing, high-pressure operations, and seamless scalability from lab to industrial scale.

Meet your mRNA product's specific needs with assay packages that provide the product and process knowledge needed to develop a quality target product profile and identify critical quality attributes.

Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.

Explore automated electrophoresis solutions for vaccine development to ensure precise sample quality control and how these innovations streamline workflows and enhance reliability in vaccine research.

Unlock next-generation nanoparticle and LNP manufacturing. Achieve high throughput, minimal waste, and superior quality with a compact, automated, and contamination-controlled system.

Watch to explore a box solution that provides flexible and scalable options for your mRNA workflows and is designed to support the evolving landscape of mRNA production.

Gain key insights into your biomolecules' structure and stability with an advanced, automated measurement technique. Unlock precise, label-free analysis across diverse sample types and conditions.

Lipid nanoparticles (LNPs) are a vital part of mRNA vaccines, as they protect the mRNA from degradation and deliver it to the cells. Discover vital solutions for the production and analysis of LNPs.

Explore advanced omics technologies, including genomics, proteomics, and microbiomics, with bioinformatics and machine learning to solve complex health challenges in diagnostics and drug development.

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Meet our OligoPilot oligonucleotide synthesizer – the next generation oligo synthesizer with scales to 150 mmol.

This innovative approach holds promise for reducing the need for extensive clinical drug-drug interaction studies, potentially streamlining the drug development process.

Discover how our advanced capabilities in Hopkinton, MA, are overcoming the challenges of large-scale RNA therapeutic manufacturing, enabling the efficient production of complex srRNA and mRNA therapies.

Design your mRNA manufacturing process with the certainty of fit-for-purpose standards for raw materials.

Struggling with mRNA integrity? Discover essential strategies to boost stability in mRNA manufacturing with innovative endonuclease-free DTT and Spermidine chemicals.

Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.

Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

Review our full range of support services to streamline manufacturing processes through to the commercialization of aseptic and lyophilized products.

The PDA Regulatory Conference 2025 Achieving CGMP Excellence: Sustainable Compliance Across the Lifecycle continues its 34-year tradition of delivering impactful content that supports the development and implementation of effective quality systems across the product lifecycle. This premier pharmaceutical CGMP conference on 08-10 September 2025 in Washington, DC will focus on strategies to manage manufacturing and quality risks while driving operational excellence and sustainable compliance. Register Now